SENP7 (NM 020654) Humaan Recombinant eiwit

The reversible posttranslational modification of proteins by the addition of small ubiquitin-like SUMO proteins (see SUMO1; MIM 601912) is required for many cellular processes. SUMO-specific proteases, such as SENP7, process SUMO precursors to generate a C-terminal diglycine motif required for the conjugation reaction. They also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]) .[supplied by OMIM, Jun 2009]

Purified recombinant protein of Human SUMO1/sentrin specific peptidase 7 (SENP7), transcript variant 1, Met1-Lys367, with N-terminal His tag, expressed in E. coli, 50ug

KIAA1707; MGC157730

57337

Q9BQF6

NM_020654

3q12.3

E. coli

N-His

>50 ug/mL as determined by microplate BCA method

> 80% as determined by SDS-PAGE and Coomassie blue staining

Liquid

25mM Tris, pH8.0, 150 mM NaCl, 10% glycerol, 1% Sarkosyl.

Druggable Genome, Protease

41.9 kDa

Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.

SENP7

Human

NP_065705

https://www.ncbi.nlm.nih.gov/gene/57337

https://www.uniprot.org/uniprot/Q9BQF6

https://www.ncbi.nlm.nih.gov/nuccore/NM_020654

https://www.ncbi.nlm.nih.gov/nuccore/NP_065705